StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultAug 12, 2026, 04:05 PM

Mannatech Q2 Net Income $1.0M, EPS $0.53; Net Sales Up $1.0M

AI Summary

Mannatech reported strong financial results for the second quarter of 2026, with net sales increasing to $26.7 million, up $1.0 million year-over-year. The company achieved a net income of $1.0 million, or $0.53 per diluted share, a significant turnaround from a net loss of $4.3 million in the same period last year. This improvement was driven by an increase in gross profit percentage to 76.9% and a 16.7% reduction in selling and administrative expenses.

Key Highlights

  • Net sales for Q2 2026 increased to $26.7 million, up $1.0 million from Q2 2025.
  • Net income for Q2 2026 was $1.0 million, or $0.53 per diluted share, compared to a net loss of $4.3 million, or $(2.27) per diluted share, in Q2 2025.
  • Gross profit as a percentage of net sales increased to 76.9% in Q2 2026 from 73.6% in Q2 2025.
  • Income from operations was $1.0 million in Q2 2026, a significant improvement from a $1.4 million loss in Q2 2025.
  • Selling and administrative expenses decreased by 16.7% to $9.0 million in Q2 2026.
  • Cash and cash equivalents were $6.0 million as of June 30, 2026, a 2.4% decrease from December 31, 2025.
  • Recruiting new associates and preferred customers increased 33.3% in Q2 2026.